Thus, our data confirmed that both EGFR inhibitors and EGFR ligands can inhibit the growth of squamous carcinoma cell colonies, and together they can counterbalance each other and enhance proliferation instead (Figure 9). The gene discussed is EGFR; the disease is squamous cell carcinoma.